The Lorazepam Injection, cataloged under National Stock Number 6505-01-411-2723, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Hikma Pharmaceuticals Usa Inc.. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-411-2723 |
| Primary Part Number | NDC00641-6003-25 |
| Item Name | Lorazepam Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Hikma Pharmaceuticals Usa Inc. |
| Status | ACTIVE |
| Controlled Substance Classification | SCHEDULE IV |
| Primary Container Content Quantity | 1.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Protective Storage Feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| Active Medicament Medicinal Strength | 4.000 MILLIGRAMS LORAZEPAM PER MILLILITER |
| Total Primary Container Quantity | 25 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00641-6003-25 PRIMARY | Hikma Pharmaceuticals Usa Inc. (USA) |
| NDC00641-6045-25 PRIMARY | Hikma Pharmaceuticals Usa Inc. (USA) |
| NDC00641-6049-25 PRIMARY | Hikma Pharmaceuticals Usa Inc. (USA) |
| Reference | Meaning |
|---|---|
| 95-0129 | 5/1 Secondary reference U.S. Government activity |
NSN 6505-01-411-2723 is a Lorazepam Injection, manufactured by Hikma Pharmaceuticals Usa Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-411-2723 has 3 manufacturer part numbers on file: NDC00641-6003-25 (Hikma Pharmaceuticals Usa Inc.), NDC00641-6045-25 (Hikma Pharmaceuticals Usa Inc.), NDC00641-6049-25 (Hikma Pharmaceuticals Usa Inc.).
Key specifications for NDC00641-6003-25: Controlled Substance Classification: SCHEDULE IV; Primary Container Content Quantity: 1.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.